OTUD3 was significantly down-regulated in heavy smokers compared to non-smoking or normal tissues, and low OTUD3 expression was significantly associated with adverse clinicopathological features, including tumor size, lymph node metastasis, pathological grading, and clinical staging [61]. Here, OTUD3 is linked to neoplasm.